Abnormal serine/threonine kinase activity has been observed in cancer and it plays an important role in the Akt (protein kinase B) phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of the rapamycin (mTOR) signaling pathway. This evidence concerns the gene MTOR and cancer.